合計 50 件の最近のインサイダー取引記録が記録されています OncoSec Medical Incorporated (ONCS), 内訳は 28 件の買い および 17 件の売り. インサイダー買い総額は $10.66M インサイダー売り総額は $1.2M.
最近活動のある主要インサイダーには Delaversano Robert J, Foster Spahr Stephany, Arch Robert H.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ONCS
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2023-02-09 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
40 |
$1.37 |
$54.80 |
1,008 |
| 2022-11-04 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
283 |
$0.37 |
$104.71 |
22,975 |
| 2022-10-07 |
Foster Spahr Stephany |
Director |
不明 |
- |
- |
- |
- |
| 2022-10-07 |
Foster Spahr Stephany |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
50,000 |
| 2022-08-05 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
284 |
$0.71 |
$201.64 |
23,258 |
| 2022-05-06 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
274 |
$0.83 |
$227.42 |
23,542 |
| 2022-05-02 |
Arch Robert H. |
Officer |
不明 |
- |
- |
- |
- |
| 2022-05-02 |
Arch Robert H. |
President and CEO |
RSU 付与(制限付株式) |
700,000 |
- |
- |
700,000 |
| 2022-02-17 |
Chi George |
Officer |
不明 |
- |
- |
- |
- |
| 2022-02-09 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
409 |
$0.88 |
$359.92 |
23,816 |
| 2021-12-17 |
Shi Lin |
Director |
不明 |
- |
- |
- |
- |
| 2021-11-01 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
343 |
$1.75 |
$600.25 |
24,225 |
| 2021-08-23 |
Zhao Yuhang |
Director |
情報に基づく買い |
4,000 |
$1.88 |
$7.52K |
12,000 |
| 2021-08-23 |
Dalesandro Margaret |
Director |
情報に基づく買い |
20,000 |
$1.89 |
$37.8K |
20,000 |
| 2021-08-20 |
Zhao Yuhang |
Director |
情報に基づく買い |
8,000 |
$1.94 |
$15.52K |
8,000 |
| 2021-08-02 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
412 |
$2.18 |
$898.16 |
24,568 |
| 2021-06-28 |
Dalesandro Margaret |
Director |
RSU 付与(制限付株式) |
37,500 |
$3.16 |
$118.5K |
37,500 |
| 2021-06-28 |
Demesa James M |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Ward Robert |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Leuthner Brian A |
Interim CEO |
RSU 付与(制限付株式) |
33,000 |
$3.16 |
$104.28K |
33,000 |
| 2021-06-28 |
Delaversano Robert J |
Vice President, Finance |
RSU 付与(制限付株式) |
35,000 |
$3.16 |
$110.6K |
35,000 |
| 2021-06-28 |
Kim Joon |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Zhao Yuhang |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Smith Kevin Raymond Merrill |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Zhou Chao |
10 Percent Owner |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Lyerly Herbert Kim |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-05-03 |
Delaversano Robert J |
VP, Finance |
情報に基づく売り |
453 |
$4.86 |
$2.2K |
24,980 |
| 2021-04-30 |
O'connor Daniel J. |
CEO and President |
情報に基づく売り |
3,172 |
$4.86 |
$15.42K |
96,097 |
| 2021-04-16 |
China Grand Pharmaceutical & Healthcare Holdings Ltd |
10 Percent Owner |
情報に基づく買い |
281,968 |
$3.45 |
$972.79K |
3,359,607 |
| 2021-02-18 |
Alpha Holdings, Inc. |
Director |
オプション行使(ITM) |
368,250 |
$3.45 |
$1.27M |
- |
| 2021-02-02 |
Leuthner Brian A |
Officer |
不明 |
- |
- |
- |
- |
| 2021-02-02 |
Leuthner Brian A |
Chief Operating Officer |
RSU 付与(制限付株式) |
150,000 |
$7.45 |
$1.12M |
150,000 |
| 2021-02-01 |
O'connor Daniel J. |
CEO and President |
情報に基づく売り |
3,413 |
$7.71 |
$26.31K |
99,269 |
| 2021-02-01 |
Delaversano Robert J |
Principal Accounting Officer |
RSU 付与(制限付株式) |
8,750 |
- |
- |
25,433 |
| 2021-01-25 |
China Grand Pharmaceutical & Healthcare Holdings Ltd |
10 Percent Owner |
情報に基づく買い |
677,839 |
$5.45 |
$3.69M |
3,077,639 |
| 2020-11-20 |
Alpha Holdings, Inc. |
Director |
情報に基づく売り |
80,000 |
$4.92 |
$393.87K |
1,350,001 |
| 2020-11-19 |
Alpha Holdings, Inc. |
Director |
情報に基づく売り |
50,000 |
$5.10 |
$255.23K |
1,430,001 |
| 2020-11-18 |
Alpha Holdings, Inc. |
Director |
情報に基づく売り |
10,999 |
$5.24 |
$57.65K |
1,480,001 |
| 2020-11-17 |
Alpha Holdings, Inc. |
Director |
情報に基づく売り |
40,000 |
$5.17 |
$206.74K |
1,531,000 |
| 2020-11-16 |
Alpha Holdings, Inc. |
Director |
情報に基づく売り |
40,000 |
$5.41 |
$216.33K |
1,571,000 |
| 2020-11-02 |
O'connor Daniel J. |
CEO and President |
情報に基づく売り |
3,280 |
$3.79 |
$12.43K |
102,682 |
| 2020-09-14 |
Dalesandro Margaret |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.43 |
$85.75K |
25,000 |
| 2020-09-14 |
Demesa James M |
Director |
RSU 付与(制限付株式) |
50,000 |
$3.43 |
$171.5K |
50,000 |
| 2020-09-14 |
Ward Robert |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.43 |
$85.75K |
25,000 |
| 2020-09-14 |
Lyerly Herbert Kim |
Director |
RSU 付与(制限付株式) |
25,000 |
$3.43 |
$85.75K |
25,000 |
| 2020-08-24 |
O'connor Daniel J. |
CEO and President |
RSU 付与(制限付株式) |
152,000 |
$3.82 |
$580.64K |
152,000 |
| 2020-08-24 |
Delaversano Robert J |
Principal Accounting Officer |
RSU 付与(制限付株式) |
27,000 |
$3.82 |
$103.14K |
27,000 |
| 2020-08-24 |
Foerter Kellie Malloy |
Chief Operating Officer |
RSU 付与(制限付株式) |
65,000 |
$3.82 |
$248.3K |
65,000 |
| 2020-08-19 |
China Grand Pharmaceutical & Healthcare Holdings Ltd |
10 Percent Owner |
情報に基づく買い |
399,800 |
$3.25 |
$1.3M |
2,399,800 |
| 2020-07-31 |
O'connor Daniel J. |
CEO and President |
情報に基づく売り |
3,133 |
$4.20 |
$13.16K |
105,962 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効